Vaccines Market Research Reports & Industry Analysis
Because of the large number of deadly diseases that have been eliminated through the proliferation of effective vaccines, vaccination is generally viewed as one of the greatest public health achievements of the 20th century. Key issues in the global vaccine market today include unequal access to vaccines, supply chain disruptions, the use of vaccines to prevent pandemics and address bioterrorism, technological innovations, and vaccine hesitancy. Learn more about this critical field with the comprehensive selection of vaccine market research reports available on MarketResearch.com.
New Vaccines Market Data and Insights
- Find data on vaccine market size segmented by region, technology, distribution channel, type, route of administration, and disease.
- Gain a deep understanding of vaccine industry dynamics, market structure, growth outlook, and competitive landscape.
- Learn about influential government initiatives and new vaccination technologies that have highly promising results.
Your Source for Expert Data and Analysis
MarketResearch.com is a trusted research partner, backed by over two decades of experience. Our clients include top investment banks, management consulting firms, and leading multinational companies within the Fortune 500. Our team of research specialists is dedicated to guiding you at every step, ensuring you have the resources and insights you need to answer your toughest research questions. Browse our full list of vaccines industry reports today.
Vaccines Industry Research & Market Reports
-
Global mRNA Vaccines and Therapeutics Competitive Landscape Professional Research Report 2024
... RNA to instruct cells in the body to produce specific proteins or trigger immune responses. In the context of vaccines, mRNA vaccines have gained significant attention for their role in protecting against infectious diseases, such ... Read More
-
Global Cell Culture Media for Vaccine Competitive Landscape Professional Research Report 2024
... the manufacturing process of vaccines. These media are designed to support the growth of specific cell lines, such as mammalian cells, insect cells, or avian cells, which are used as hosts for viral replication or ... Read More
-
Global Poultry Vaccines Competitive Landscape Professional Research Report 2024
... in preventing and controlling the spread of various viral, bacterial, and parasitic diseases that can adversely impact poultry health and production. Poultry vaccines are administered through various methods, including injection, drinking water, or spray applications. ... Read More
-
Global Avian Influenza Vaccines Competitive Landscape Professional Research Report 2024
... used as a part of disease control measures, especially in situations where there is an outbreak of avian influenza. The vaccine works by stimulating the immune system of the bird, so that it produces a ... Read More
-
Single-Use Bioreactor Market, By Product (Single-use Bioreactor Systems, Media Bags, Filtration Assemblies, and Other Products), By Cell Type (Mammalian Cell, Bacteria, Yeast, and Other Cell Types), By Molecule Type (Vaccines, Monoclonal Antibodies, Stem Cells, and Recombinant Proteins), By End User (Pharmaceutical and Biopharmaceutical Industries, Contract Research Organizations, Academic & Research Institutes, and Other End Users), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Recombinant Proteins), By End User (Pharmaceutical and Biopharmaceutical Industries, Contract Research Organizations, Academic & Research Institutes, and Other End Users), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) The single-use ... Read More
-
Protein Engineering Market, By Product Type (Modified Enzymes, Insulin, Monoclonal Antibodies, Coagulation Factors , Vaccines , Growth Factors, and Other Product Types), By Technology (Irrational Protein Design and Rational Protein Design ), By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic Institutions, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic Institutions, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Protein engineering is the process of developing useful proteins through rational ... Read More
-
Prefilled Syringe Packaging Market Size, Trends, Analysis, and Outlook By Type (Glass Material, Plastic Material), By Application (Vaccines, Antithrombotic Drugs), by Country, Segment, and Companies, 2024-2030
... to register a 5.4% growth from $1.2 Billion in 2024 to 1.6 Billion in 2030, presenting significant growth prospects for companies operating in the industry. The Prefilled Syringe Packaging market study analyzes the study across ... Read More
-
Ebola Virus Vaccine Market (Vaccine Type: cAd3-ZEBOV and rVSV-ZEBOV; and Route of Administration: Oral and Intravenous) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... TMR’s report on the global Ebola virus vaccine market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period ... Read More
-
Cholera Vaccines Market by Type (Inactivated Vaccine, Live Attenuated Vaccine), Method of Administration (Injectable Vaccines, Oral Vaccines), End User, Age Group - Global Forecast 2024-2030
... million in 2023 and expected to reach USD 307.02 million in 2024, at a CAGR 7.32% to reach USD 469.83 million by 2030. Cholera vaccines are biological preparations designed to protect individuals from cholera, a ... Read More
-
Vaccine Contract Manufacturing Market by Type (Attenuated Vaccine, DNA Vaccines, Inactivated Vaccine), Function (Downstream, Upstream), Application - Global Forecast 2024-2030
... expected to reach USD 5.51 billion in 2024, at a CAGR 9.21% to reach USD 9.39 billion by 2030. Vaccine contract manufacturing refers to outsourcing vaccine production processes to third-party organizations, known as contract manufacturing ... Read More
-
Porcine Vaccines Market by Indication (Arthritis, Diarrhea, Porcine Circovirus Associated Disease), Technology (Conjugate Vaccines, DNA Vaccines, Inactivated Vaccines), End User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 1.82 billion in 2024, at a CAGR 6.72% to reach USD 2.70 billion by 2030. Porcine vaccines are immunological preparations designed to prevent various swine diseases in pigs. ... Read More
-
Veterinary Vaccines Market by Animal Type (Aquaculture, Companion Animals, Livestock), Technology (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines), Route of Administration, Distribution Channel - Global Forecast 2024-2030
... USD 9.82 billion in 2023 and expected to reach USD 10.40 billion in 2024, at a CAGR 6.43% to reach USD 15.19 billion by 2030. Veterinary vaccines are biologically prepared substances that stimulate an animal's ... Read More
-
Vaccine Adjuvants Market by Product (Adjuvant Emulsions, Combination Adjuvants, Mineral Adjuvants), Route of Administration (Intradermal, Intramuscular, Intranasal), Disease, Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 884.18 million in 2024, at a CAGR 7.88% to reach USD 1,404.20 million by 2030. Vaccine adjuvants are essential components in the formulation of vaccines, which enhance and modulate ... Read More
-
Travel Vaccines Market by Type (Attenuated Vaccines, Conjugate Vaccines, DNA Vaccines), Disease (DPT, Hepatitis A, Hepatitis B) - Global Forecast 2024-2030
... expected to reach USD 9.09 billion in 2024, at a CAGR 10.06% to reach USD 16.18 billion by 2030. The travel vaccines market encompasses the production, distribution, and administration of immunizations recommended or required for ... Read More
-
Pneumococcal Vaccine Market by Type (Conjugate Vaccines, Polysaccharide Vaccines), Indication (Bronchitis, Meningitis, Pneumonia), Age Group, Distribution - Global Forecast 2024-2030
... to reach USD 11.56 billion in 2024, at a CAGR 7.92% to reach USD 18.30 billion by 2030. The pneumococcal vaccine is designed to protect against infections caused by the streptococcus pneumoniae bacteria. These infections ... Read More
-
Microcarriers Market by Product (Consumables, Equipment), Application (Biologics Manufacturing, Cell Therapy, Vaccine Manufacturing), End User - Global Forecast 2024-2030
... USD 2.37 billion in 2024, at a CAGR 9.99% to reach USD 4.22 billion by 2030. Microcarriers are small spherical beads made from materials such as dextran, polystyrene, gelatin, or glass that provide a surface ... Read More
-
Adult Bovine Serum Market by Origin (Australia-Sourced, New Zealand-Sourced, North America-Sourced), Application (Bioprocessing, Cell Culture, Vaccine Production), End-User - Global Forecast 2024-2030
... 2023 and expected to reach USD 148.18 million in 2024, at a CAGR 5.61% to reach USD 205.99 million by 2030. Adult bovine serum (ABS) is an animal-derived serum extracted from the blood of adult ... Read More
-
COVID-19 Clinical Trials Market by Product (Therapeutics, Vaccines), Phase (Phase I, Phase II, Phase III) - Global Forecast 2024-2030
... to reach USD 6.79 billion in 2024, at a CAGR 13.93% to reach USD 14.84 billion by 2030. The COVID-19 clinical trials market comprises all research activities and trials to examine the efficacy and safety ... Read More
-
Vaccines Market by Type (Monovalent Vaccine, Multivalent Vaccine), Technology Type (Inactivated Vaccines, Live-Attenuated Vaccines, Messenger RNA (mRNA) Vaccines), Indication, Route of administration, Age Group - Global Forecast 2024-2030
... USD 55.66 billion in 2023 and expected to reach USD 59.94 billion in 2024, at a CAGR 7.79% to reach USD 94.14 billion by 2030. Vaccines are biological preparations that equip the body's immune system ... Read More
-
Foot & Mouth Disease Vaccines Market by Product (Conventional, Emergency), Type (DNA Vaccines, Inactivated Vaccines, Live Attenuated Vaccines), Application, Distribution Channel - Global Forecast 2024-2030
... at USD 2.69 billion in 2023 and expected to reach USD 2.93 billion in 2024, at a CAGR 9.10% to reach USD 4.95 billion by 2030. Foot and mouth disease vaccines are biologics designed to ... Read More
-
Europe AAV Contract Development and Manufacturing Organizations Market Size study, by Workflow (Upstream Processing, Downstream Processing), by Culture Type, by Application (Cell & Gene Therapy Development, Vaccine Development, Biopharmaceutical & Pharmaceutical Discovery, Biomedical Research), by End-User and Country Forecasts 2022-2032
... End-User and Country Forecasts 2022-2032 Europe AAV Contract Development and Manufacturing Organizations Market is valued at approximately USD 167.67 million in 2023 and is anticipated to grow with a healthy growth rate of more than ... Read More
-
Global AAV Contract Development and Manufacturing Organizations Market Size Study, by Workflow (Upstream Processing, Downstream Processing), by Culture Type, by Application (Cell & Gene Therapy Development, Vaccine Development, Biopharmaceutical & Pharmaceutical Discovery, Biomedical Research), by End-User and Regional Forecasts 2022-2032
... End-User and Regional Forecasts 2022-2032 Global AAV Contract Development and Manufacturing Organizations Market is valued at approximately USD 621 million in 2023 and is anticipated to grow with a healthy growth rate of more than ... Read More
-
US AAV Contract Development and Manufacturing Organizations Market Size study, by Workflow (Upstream Processing, Downstream Processing), by Culture Type, by Application (Cell & Gene Therapy Development, Vaccine Development, Biopharmaceutical & Pharmaceutical Discovery, Biomedical Research), by End-User Forecasts 2022-2032
... End-User Forecasts 2022-2032 US AAV Contract Development and Manufacturing Organizations Market is valued at approximately USD 201.14 million in 2023 and is anticipated to grow with a healthy growth rate of more than 4.85% over ... Read More
-
Asia Pacific AAV Contract Development and Manufacturing Organizations Market Size study, by Workflow (Upstream Processing, Downstream Processing), by Culture Type, by Application (Cell & Gene Therapy Development, Vaccine Development, Biopharmaceutical & Pharmaceutical Discovery, Biomedical Research), by End-User and Country Forecasts 2022-2032
... by End-User and Country Forecasts 2022-2032 Asia Pacific AAV Contract Development and Manufacturing Organizations Market is valued at approximately USD 130.41 million in 2023 and is anticipated to grow with a healthy growth rate of ... Read More
-
Global Messenger RNA (mRNA)-based Vaccines and Therapeutics – Market Insight, Epidemiology, and Market Forecast – 2034
... an in-depth understanding of the Global Messenger RNA (mRNA)-based Vaccines and Therapeutics, historical and forecasted epidemiology as well as the Global Messenger RNA (mRNA)-based Vaccines and Therapeutics market trends in the United States, EU5 (Germany, ... Read More
Research Assistance
